---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004554"
form_type: "8-K"
ticker: "GNLX"
cik: "0001231457"
company_name: "GENELUX Corp"
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T03:55:08.804805+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Genelux CFO Lourie Zak resigns; Matt Pulisic appointed CFO with $410k salary, 275k option

## Summary
- Lourie Zak resigned as CFO effective Jan 29, 2025; separation includes $180k cash payment (6 months salary) and advisory role through Aug 29, 2025.
- Matt Pulisic appointed CFO effective Jan 30, 2025; previously VP Finance at Arrowhead Pharmaceuticals.
- Pulisic receives base salary of $410,000/year, target bonus of 40% of base, and option to purchase 275,000 shares at $3.95/share.
- Option vests over 4 years (25% after one year, then monthly); full acceleration upon change in control.
- Pulisic eligible for severance: 6 months base salary without cause, 12 months base salary if termination within change in control period.

## SEC filing metadata
- accession: 0001493152-25-004554
- form_type: 8-K
- ticker: GNLX
- cik: 0001231457
- company_name: GENELUX Corp
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004554
- JSON: https://secwatch.observer/filing/0001493152-25-004554.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004554.txt

## Key facts
- Executive change
  Matt Pulisic was appointed as Chief Financial Officer at GENELUX Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On February 3, 2025, the Company announced the appointment of Matt Pulisic as the Company’s Chief Financial Officer, effective as of January 30, 2025 (the “ Effective Date ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm
- Executive change
  Lourie Zak resigned as Chief Financial Officer at GENELUX Corp.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On January 29, 2025 (the “ Separation Date ”), Lourie Zak resigned as Chief Financial Officer of Genelux Corporation (the “ Company ”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.